Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Autoimmune Disorders

Free Subscription 06.04.2026 3 BMC Neurol 2 Curr Opin Immunol 1 Diabet Med 1 Diabetes Res Clin Pract 1 Intern Med 1 J Autoimmun 1 J Clin Endocrinol Metab 3 J Neuroimmunol 5 J Neurol 4 J Rheumatol 4 Kidney Int 6 Mult Scler 2 N Engl J Med 1 Neurology 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. HUANG M, Jia Q, Ouyang Y, Feng X, et al
   Autoimmune glial fibrillary acidic protein astrocytopathy with full-length spinal cord lesions: a case report and literature review.
   BMC Neurol. 2026 Mar 31. doi: 10.1186/s12883-026-04691.
   PubMed        
   
   
2. LUAN Z, Liang Z, Song F
   Coexistence of anti-GluK2 and anti-LGI1 antibodies in a patient with autoimmune encephalitis: a rare case report and literature review.
   BMC Neurol. 2026 Mar 31. doi: 10.1186/s12883-026-04845.
   PubMed        
   
   
3. SONG Y, Zhao H, Wu Q, Xie S, et al
   Association of the along?perivascular space (ALPS) index and white matter volume with cognitive dysfunction in relapsing?remitting multiple sclerosis patients.
   BMC Neurol. 2026 Mar 27. doi: 10.1186/s12883-026-04826.
   PubMed        
   
   

   
   Curr Opin Immunol

4. MATHEOUD D, Akbar I, Hercun J, Stratton JA, et al
   A liver-mitochondria-immune axis in Parkinson's disease: emerging perspectives on a hepatic origin for mitochondrial autoimmunity as a driver of Parkinson's disease.
   Curr Opin Immunol. 2026;100:102761.
   PubMed         Abstract available
   
   
5. YALAVARTHI S, NaveenKumar SK, Knight JS
   Neutrophils and monocytes in the pathogenesis of antiphospholipid syndrome.
   Curr Opin Immunol. 2026;100:102768.
   PubMed         Abstract available
   
   

   
   Diabet Med

6. LI Y, Qu K, Yang Q, Zhang J, et al
   The clinical spectrum and causal relationship assessment of checkpoint inhibitor-associated autoimmune diabetes mellitus (CIADM): A retrospective observational study.
   Diabet Med. 2026 Mar 31:e70316. doi: 10.1111/dme.70316.
   PubMed         Abstract available
   
   

   
   Diabetes Res Clin Pract

7. LEHAVI M, Gil Margolis M, Yakobovich-Gavan M, Weizman S, et al
   Islet autoantibody profiles at diagnosis of childhood type 1 Diabetes: Age-Dependent heterogeneity and clinical implications.
   Diabetes Res Clin Pract. 2026;235:113229.
   PubMed         Abstract available
   
   

   
   Intern Med

8. HISHINUMA M, Hasegawa M, Minatoguchi S, Umeda R, et al
   Vanishing Bile Duct Syndrome Caused by a Treatment Regimen Including Avacopan for Microscopic Polyangiitis.
   Intern Med. 2026;65:1017-1022.
   PubMed         Abstract available
   
   

   
   J Autoimmun

9. HAN AR, Alzahrani M, Luu TV, Dambaeva S, et al
   Autoimmune modulation of immune-endocrine-metabolic regulation of ovarian reserve: A cohort study of 803 women.
   J Autoimmun. 2026;160:103552.
   PubMed         Abstract available
   
   

   
   J Clin Endocrinol Metab

10. ABBATE M, Vincenzi G, Mora S, Tarantola G, et al
    The FT3/FT4 Ratio Predicts Relapse After Antithyroid Drug Withdrawal in Pediatric Autoimmune Hyperthyroidism.
    J Clin Endocrinol Metab. 2026 Mar 31:dgag130. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

11. GASTALDI M, Ramanathan S, Franciotta D
    Autoantibody-mediated disorders of the central and peripheral nervous system.
    J Neuroimmunol. 2026;415:578915.
    PubMed        
    
    
12. MOODLEY K
    Rethinking rituximab in neuroimmunology: Real-world efficacy, cost-effectiveness, and long-term remission.
    J Neuroimmunol. 2026;415:578891.
    PubMed         Abstract available
    
    
13. RIVEROS D, Buyukkurt A, Newsome SD
    Understanding stiff-person syndrome: Epidemiological trends, diagnostic challenges, and treatment advances.
    J Neuroimmunol. 2026;415:578888.
    PubMed         Abstract available
    
    

    
    J Neurol

14. FILIPPAKOPOULOU E, Gavriilaki M, Arnaoutoglou M, Kimiskidis V, et al
    Efficacy and safety of complement inhibitors and FcRn blockers in generalized AChR antibody-positive myasthenia gravis: a meta-analysis.
    J Neurol. 2026;273:244.
    PubMed         Abstract available
    
    
15. NERI F, Bianchi A, Luchetti L, Breccia D, et al
    Functional head impulse testing for detection and quantification of vestibular dysfunction in multiple sclerosis.
    J Neurol. 2026;273:245.
    PubMed         Abstract available
    
    
16. HAYES MTG, Beadnall HN, Merlo D, Monif M, et al
    Cross-sectional brain volumetric measures and disability outcomes in relapsing-remitting multiple sclerosis.
    J Neurol. 2026;273:243.
    PubMed         Abstract available
    
    
17. GUO J, Olsson T, Johansson E, Alfredsson L, et al
    Long-term disability after initiation of platform versus high-efficacy disease-modifying therapy in relapsing-onset multiple sclerosis.
    J Neurol. 2026;273:240.
    PubMed         Abstract available
    
    
18. DAMMAN SF, Rai SM, Shrestha R, Shaikh AG, et al
    Alternative diagnoses in patients referred to neuroimmunology for autoimmune encephalitis evaluation.
    J Neurol. 2026;273:239.
    PubMed         Abstract available
    
    

    
    J Rheumatol

19. MILLER-BARMAK A, Mandel-Shorer N, Tobias L, Butbul Aviel Y, et al
    Antiphospholipid Syndrome in Identical Pediatric Twins.
    J Rheumatol. 2026 Apr 1:jrheum.2025-0472. doi: 10.3899/jrheum.2025-0472.
    PubMed        
    
    
20. MCMAHON M, Skaggs BJ
    Rethinking Cardiovascular Screening in Systemic Lupus Erythematosus.
    J Rheumatol. 2026 Apr 1:jrheum.2026-0136. doi: 10.3899/jrheum.2026-0136.
    PubMed        
    
    
21. SONG J, Jiang H, Wang X, Gong K, et al
    Evolution of the Diagnostic Paradigm for Giant Cell Arteritis: From Histopathology to Multi-Modal Imaging Integration Running title: GCA: Histology to Imaging.
    J Rheumatol. 2026 Apr 1:jrheum.2025-1205. doi: 10.3899/jrheum.2025-1205.
    PubMed         Abstract available
    
    
22. HARRIS JG, Singleton JH, Ting TV, Oberle EJ, et al
    Evaluation of Health Disparities in Outcomes of Patients With Juvenile Idiopathic Arthritis.
    J Rheumatol. 2026;53:435-442.
    PubMed         Abstract available
    
    

    
    Kidney Int

23. YAP DYH, Chan SCW, Wong PYH, Wong S, et al
    A prospective multi-center randomized controlled trial preemptive increase in immunosuppression for asymptomatic serological reactivation in patients with lupus nephritis in clinical remission.
    Kidney Int. 2026 Mar 27:S0085-2538(26)00238-3. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available
    
    
24. AL-RABADI L, Storey A, Abuelsamen T, Takayama S, et al
    Serine Protease HTRA1 is a Common Autoantigen in Membranous Nephropathy in Patients of 80 Years and Older.
    Kidney Int. 2026 Mar 27:S0085-2538(26)00237-1. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available
    
    
25. PETIT-PAITEL A, Bihl F, Lambeau G
    Autoimmunoglobulin-triggered extracellular vesicles as New Players in Membranous Nephropathy: Friends or Foes?
    Kidney Int. 2026 Mar 26:S0085-2538(26)00231-0. doi: 10.1016/j.kint.2026.
    PubMed        
    
    
26. ROVIN BH, Barratt J, Cook HT, Noronha IL, et al
    Complement inhibitors and B-cell modifying agents for IgA nephropathy- a KDIGO commentary.
    Kidney Int. 2028 Mar 31:S0085-2538(26)00213-9. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available
    
    

    
    Mult Scler

27. STRIJBIS E, Mostert J, D'Haeseleer M, Moral E, et al
    Diminishing returns of disease-modifying treatment in older participants of multiple sclerosis clinical trials.
    Mult Scler. 2026;32:429-439.
    PubMed         Abstract available
    
    
28. BENNETT JL, Bhattacharyya S, Zabeti A, Levy M, et al
    Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial.
    Mult Scler. 2026;32:396-408.
    PubMed         Abstract available
    
    
29. ANDERSEN ML, Anru PL, Sorensen E, Jolving LR, et al
    Treatment-requiring postpartum depression in mothers with multiple sclerosis: A nationwide cohort study.
    Mult Scler. 2026 Apr 3:13524585261429255. doi: 10.1177/13524585261429255.
    PubMed         Abstract available
    
    
30. CAMPAGNA MP, Bove R
    Menopause is a progression event in multiple sclerosis: Yes.
    Mult Scler. 2026 Apr 1:13524585261429827. doi: 10.1177/13524585261429827.
    PubMed        
    
    
31. BACCHETTI A, McCormack B, Lin TY, Filippatou AG, et al
    Influence of OSCAR-IB criteria on test-retest reliability of Spectralis SD-OCT retinal thickness measurements in people with Multiple Sclerosis.
    Mult Scler. 2026 Mar 29:13524585261426768. doi: 10.1177/13524585261426768.
    PubMed         Abstract available
    
    
32. GIOVANNONI G
    Immunological and other multiple sclerosis prodromes.
    Mult Scler. 2026;32:355-358.
    PubMed        
    
    

    
    N Engl J Med

33. BARRATT J, Eren N, Kashihara N, Maes B, et al
    Iptacopan in IgA Nephropathy - Final 24-Month Data.
    N Engl J Med. 2026 Mar 29. doi: 10.1056/NEJMoa2600743.
    PubMed         Abstract available
    
    
34. VLEUGELS RA, Paik JJ, Bauer Ventura I, Mangold AR, et al
    A Phase 3 Trial of Brepocitinib in Dermatomyositis.
    N Engl J Med. 2026 Mar 28. doi: 10.1056/NEJMoa2503531.
    PubMed         Abstract available
    
    

    
    Neurology

35. TOURNIER A, Gavoille A, Pique J, Levraut M, et al
    Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS.
    Neurology. 2026;106:e214806.
    PubMed         Abstract available
    
    

    
    Thyroid

36. CHOI S, Shah SV, Chandraparnik P, Wai KM, et al
    Corticosteroids Versus Teprotumumab for the Treatment of Thyroid Eye Disease. Does Either Mitigate the Need for Additional Treatments?
    Thyroid. 2025 Dec 17. doi: 10.1177/10507256251408731.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum